Indication
Growth failure due to Prader-Willi syndrome
Growth failure due to Prader-Willi syndrome is a pediatric endocrine and neurodevelopmental manifestation marked by subnormal linear growth velocity and diminished final adult height. Read more about Growth failure due to Prader-Willi syndrome
7 drugs 3 manufacturers
Drugs that treat it
Common Growth failure due to Prader-Willi syndrome therapies.
GENOTROPIN (somatropin)
NORDITROPIN FLEXPRO (somatropin)
NORDITROPIN FLEXPRO (somatropin)
GENOTROPIN (somatropin)
GENOTROPIN (somatropin)
GENOTROPIN MINIQUICK (somatropin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGrowth failure due to Prader-Willi syndrome is a pediatric endocrine and neurodevelopmental manifestation marked by subnormal linear growth velocity and diminished final adult height.
Occurring in children with Prader-Willi syndrome—a rare genetic condition caused by the loss of paternally expressed genes in the chromosome 15q11–q13 region—this growth deficit is primarily driven by hypothalamic dysfunction leading to impaired growth hormone secretion and low circulating insulin-like growth factor 1 (IGF-1) levels.
Clinically, affected pediatric patients present with marked short stature, delayed bone age, neonatal muscular hypotonia, and altered body composition characterized by reduced lean muscle mass and increased adiposity.
- pfmjournal.org
Growth failure due to Prader-Willi syndrome is a pediatric endocrine and neurodevelopmental manifestation marked by subnormal linear growth velocity and diminished final adult height Occurring in children with Prader-Willi syndrome—a rare genetic condition caused by the loss of paternally expressed genes in the chromosome 15q11–q13 region—this growth deficit is primarily driven by hypothalamic dysfunction leading to impaired growth hormone secretion and low circulating insulin-like growth factor...
- nih.gov
Growth failure due to Prader-Willi syndrome is a pediatric endocrine and neurodevelopmental manifestation marked by subnormal linear growth velocity and diminished final adult height
- nih.gov
Occurring in children with Prader-Willi syndrome—a rare genetic condition caused by the loss of paternally expressed genes in the chromosome 15q11–q13 region—this growth deficit is primarily driven by hypothalamic dysfunction leading to impaired growth hormone secretion and low circulating insulin-like growth factor 1 (IGF-1) levels
- fpwr.org
Clinically, affected pediatric patients present with marked short stature, delayed bone age, neonatal muscular hypotonia, and altered body composition characterized by reduced lean muscle mass and increased adiposity
- medlineplus.gov
Clinically, affected pediatric patients present with marked short stature, delayed bone age, neonatal muscular hypotonia, and altered body composition characterized by reduced lean muscle mass and increased adiposity
Personalize your experience
Follow Growth failure due to Prader-Willi syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.